Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a80cbaaeee718664126e579cf4e41c2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-79 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-79 |
filingDate |
2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9ac4f7be23fd3d88390f9201c24bb35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1b1afe59f653240a124bbfcf6264220 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_151e1b02a0fd6d9fe51a886e5109a71c |
publicationDate |
2020-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020190048-A1 |
titleOfInvention |
Highly purified pharmaceutical grade tasimelteon |
abstract |
A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities. |
priorityDate |
2014-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |